Three-dimensional structure of a Nanobody® (modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.

Home News room Press releases > 2008
Press Releases

2008

12/12/2008
ABLYNX REPORTS POSITIVE PHASE Ib RESULTS FOR ITS ANTI-THROMBOTIC NANOBODY® ALX-0081
NL

10/12/2008
ABLYNX REACHES MILESTONE IN TNF-alpha NANOBODY® COLLABORATION AS WYETH PHARMACEUTICALS INITIATES PHASE I
NL

08/12/2008
ABLYNX EXPANDS ITS ANTI-THROMBOTIC PORTFOLIO AND ANNOUNCES INITIATION OF A PHASE I STUDYFOR ALX-0681
NL

19/11/2008
ABLYNX PROVIDES A BUSINESS UPDATE FOR THE THIRD QUARTER 2008
NL

05/11/2008
ABLYNX NV - TRANSPARENCY NOTIFICATION
NL

20/10/2008
ABLYNX SECURES NEW FACILITIES TO SUPPORT LONG-TERM GROWTH
NL

10/10/2008
ABLYNX PROVIDES AN R&D UPDATE ANNOUNCING IT HAS SUCCESSFULLY GENERATED NANOBODIES® AGAINST GPCRs AND PRESENTS NEW PRECLINICAL DEVELOPMENT RANKL PROGRAMME
NL

03/10/2008
ABLYNX IS AWARDED €1.8 MILLION GRANT TO EXPLORE NOVEL METHODS FOR USES OF NANOBODIES®
NL

12/09/2008
PUBLICATION IN ACCORDANCE WITH THE ACT OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS
NL

04/09/2008
ABLYNX AND MERCK SERONO ENTER INTO AN AGREEMENT TO CO-DISCOVER AND CO-DEVELOP NANOBODIES®
NL

28/08/2008
ABLYNX ANNOUNCES HALF-YEAR RESULTS FOR 2008
NL

21/08/2008
ABLYNX WILL ANNOUNCE HALF YEAR RESULTS FOR 2008 ON 28 AUGUST 2008
NL

21/08/2008
BOEHRINGER INGELHEIM EXTENDS RESEARCH COLLABORATION WITH ABLYNX FOR ALZHEIMER'S DISEASE
NL

28/05/2008
ABLYNX ANNOUNCES INITIATION OF A PHASE IB STUDY IN PATIENTS FOR ALX-0081 AND PROVIDES A BUSINESS UPDATE FOR THE FIRST QUARTER 2008
NL

27/04/2008
ABLYNX ANNOUNCES SENIOR MANAGEMENT CHANGE
NL

28/02/2008
ABLYNX ANNOUNCES FULL YEAR RESULTS FOR 2007
NL

21/02/2008
ABLYNX WILL ANNOUNCE FULL YEAR RESULTS FOR 2007 ON 28 FEBRUARY 2008
NL

19/02/2008
ABLYNX RECEIVES MILESTONE PAYMENT FROM NANOBODY® DISCOVERY AND DEVELOPMENT ALLIANCE
NL

05/02/2008
ABLYNX RESPONDS TO REQUEST FOR ARBITRATION FROM DOMANTIS
NL

 

Press releases

News archive

Email alerts

If you would like to receive updates on the company news, please
click here